Novel Gene STS 22
AssigneeDsm IP Assets B.V.
InventorsMarie-Gabrielle Beuzelin-Ollivier, Bastian Chevreux, Manuela Dalluege, Markus G. Goese, Connie Lee, Anja Meury, Nigel J. Mouncey, Masako Shinjoh
Life of this patent
Estimating the term…
Loading patent…
AssigneeDsm IP Assets B.V.
InventorsMarie-Gabrielle Beuzelin-Ollivier, Bastian Chevreux, Manuela Dalluege, Markus G. Goese, Connie Lee, Anja Meury, Nigel J. Mouncey, Masako Shinjoh
Estimating the term…
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
A polynucleotide selected from the group consisting of:
Process for the production of a microorganism capable of producing Vitamin C, comprising the step of altering said microorganism so that the microorganism produces a polypeptide with reduced or abolished sugar transporter and/or sugar alcohol transporter activity leading to an improved yield and/or efficiency of production of Vitamin C produced by said microorganism.
Dependencies are inferred from the claim text.